Biohaven Pharmaceutical Holding Company Ltd. (BHVN) Fundamentals

Biohaven Pharmaceutical Holding Co Ltd is a clinical-stage biopharmaceutical company. It has a portfolio of late-stage product candidates targeting neurological diseases, including rare disorders. The company product candidates are based on multiple mechanisms-calcitonin gene-related peptide receptor antagonists, glutamate modulators and myeloperoxidase inhibitor. Its pipeline products include BHV-3100, BHV5000, BHV5500, among others.
SHARE INFORMATION
Market Cap$ 10,830,578,127
Shares Outstanding71,645,023
Float64,564,365
Percent Float90.12%
Short Interest0.00
Short Percent Float0.0%
Short Interest Ratio0.00
Short Interest Date-
Latest Fiscal Dividend Per Share$ 0.00
Latest Fiscal Revenue$ 462,509,000
Latest Fiscal EPS$ -13.13
Latest Fiscal Date2021-12-31
DIVIDENDS
Dividend (3 Years)$ 0.00
Dividend (5 Years)$ 0.00
Ex Dividend Date-
Dividend Rate$ 0.00
Dividend Yield0.0%
Payment Cash-
HOLDERS
Institutions782
Institutional Holdings Date2022-09-30
Institutional Bought Previous 3 Months6,945,979
Institutional Holdings Percent122.1%
Institutional Sold Previous 3 Months35,852,806
Insider Holdings Date2022-08-31
Insider Bought Previous 3 Months38,000
Insider Holdings Percent9.2
Insider Sold Previous 3 Months-
Insider Shares Owned6,592,839
TRADING INFO
52 Week High$ 152.56
52 Week Low$ 77.10
52 Week High Change$ 11.52
21 Day Moving Average$ 148.4257
21 Day Extended Moving Average$ 150.8707
50 Day Moving Average$ 145.7946
50 Day Extended Moving Average$ 148.6599
200 Day Moving Average$ 130.4591
200 Day Extended Moving Average$ 135.4855
10 Day Average Volume1,724,586
20 Day Average Volume1,221,044
30 Day Average Volume956,571
50 Day Average Volume771,817
Alpha0.027697
Beta1.0364
Standard Deviation0.168082
R20.096793
7 Day Price Change$ -0.59
7 Day Percent Change-0.39%
21 Day Price Change$ 4.10
21 Day Percent Change2.79%
30 Day Price Change$ 5.43
30 Day Percent Change3.72%
Month to Date Price Change$ 5.43
Month to Date Percent Change3.72%
Quarter to Date Price Change$ 8.98
Quarter to Date Percent Change6.31%
180 Day Price Change$ 35.46
180 Day Percent Change30.65%
200 Day Price Change$ 35.46
200 Day Percent Change30.65%
Year to Date Price Change$ 16.69
Year to Date Percent Change12.41%

Biohaven Pharmaceutical Holding Company Ltd. (BHVN) Key Ratios

PROFITABILITY
EBIT Margin-87.1%
EBITDA Margin-84.4%
Pre-Tax Profit Margin0.0%
Profit Margin Count-77.63%
Gross Margin85.6%
Profit Margin TOT-77.63%
INCOME STATEMENTS
Revenue$ 723,944,000
Revenue Per Share$ 10.1046
Revenue (3 Years)$ 0.00
Revenue (5 Years)$ 0.00
FINANCIAL STRENGTH
Price to Tangible Book-13.50
Total Debt To Equity0.00
Int Coverage-4.70
Current Ratio1.70
Leverage Ratio-1.90
Quick Ratio1.30
Long Term Debt To Capital0.00
VALUATION MEASURES
PE Ratio-10.20
Enterprise Value$ 11,042,075,126
Price to Sales14.9605
Price to Free Cash-26.50
PE High Last 5 Years-8.50
Price To Book0.00
Price To Cash Flow0.00
PE Low Last 5 Years-5.50
Price to Tangible Book-13.50
MANAGEMENT EFFECTIVENESS
Receivables Turnover3.10
Invoice Turnover1.40
Assets Turnover0.70
Return Assets-95.74
Return on Equity169.96
Return on Capital-751.37

Biohaven Pharmaceutical Holding Company Ltd. (BHVN) Profile

PROFILE INFO
Issue TypeCS
SEC TypeEQS
AuditorErnst & Young LLP
CEOVlad Coric
Emplyoees928
Last AuditUQ
CIK0001689813
IndustryBiotechnology
SectorHealthcare
NAICSPharmaceutical Preparation Manufacturing(325412)
CONTACT INFO
AddressC/o Biohaven Pharmaceuticals, Inc.
215 Church Street
New Haven, CT 6510
Websitehttps://www.biohavenpharma.com
Facsimile-
Telephone+1 203 404-0410
EmailVlad.Coric@biohavenpharma.com
Your Recent History
NYSE
BHVN
Biohaven
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to ADVFN
Register Now
NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V:us D:20221003 02:06:20